Cite
HARVARD Citation
Coates, L. et al. (2022). Safety and Efficacy of Bimekizumab in Patients With Active Psoriatic Arthritis: Three‐Year Results From a Phase IIb Randomized Controlled Trial and Its Open‐Label Extension Study. Arthritis & rheumatology. 74 (12), pp. 1959-1970. [Online].